Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating
Patients With Hematologic Cancer
Basic Study Information
Purpose:Location: James P. Wilmot Cancer Center at University of Rochester Medical Center
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs
chemotherapy use different ways to stop cancer cells from dividing so they stop growing
die. Combining chemotherapy with donor peripheral stem cell transplantation may allow
doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining total-body irradiation
fludarabine and donor peripheral stem cell transplantation in treating patients who
Study Contact Information
Additional Study Details
Thank you for contacting us. People like you are helping URMC make our community and
world a healthier place. We sincerely appreciate your effort. A member of our research
team will be in touch with you.
Trial Not Found
The study you are looking for is not active at this time.
Return to Search